NCT07443787

Brief Summary

This study aims to evaluate body weight status, lifestyle patterns, and cardiometabolic risk in women in remission from breast cancer undergoing adjuvant hormone therapy, and to assess the effects of a structured nutritional intervention based on the Mediterranean diet combined with physical activity promotion. A total of 150 women treated with adjuvant hormone therapy are recruited from the oncology department of Akid Othmane Hospital in Oran, Algeria. Participants include women receiving tamoxifen or aromatase inhibitors. Baseline assessments include anthropometric measurements (body weight, body mass index, waist and hip circumferences), socioeconomic characteristics, and lifestyle evaluation. Dietary intake is assessed using 24-hour dietary recalls and 3-day food records. Total energy intake, macronutrient and micronutrient composition, dietary habits, meal distribution, and adherence to the Mediterranean diet (MEDAS score) are evaluated. Physical activity level, sedentary behavior, daily energy expenditure, and energy balance are also determined. Cardiometabolic risk is assessed through measurement of blood pressure, fasting blood glucose, lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides), uric acid, albumin, creatinine, urea, and calculation of atherogenic ratios. A structured educational program promoting adherence to the Mediterranean diet and increased physical activity is implemented. Anthropometric, dietary, lifestyle, and cardiometabolic parameters are monitored over time to evaluate changes associated with the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started May 2022

Typical duration for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 17, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

2.8 years

First QC Date

February 17, 2026

Last Update Submit

February 26, 2026

Conditions

Keywords

Dietary assessmentMediterranean dietCardiovascular riskBreast cancer survivorsphysical activityEndocrine therapy

Outcome Measures

Primary Outcomes (1)

  • Change in waist circumference

    Change in waist circumference measured in centimeters between baseline and after 3 months of lifestyle intervention.

    Baseline and 3 months

Secondary Outcomes (3)

  • Change in body mass index (BMI)

    Time Frame: Baseline and 3 months

  • Change in lipid profile

    Baseline and 3 months

  • Change in systolic and diastolic blood pressure

    Baseline and 3 months

Study Arms (1)

Lifestyle intervention group

OTHER

Breast cancer patients receiving a Mediterranean diet intervention combined with physical activity promotion for 3 months, with assessments conducted at baseline and after the intervention.

Behavioral: Mediterranean dietBehavioral: Physical activity promotion

Interventions

Dietary counseling and guidance to promote adherence to the Mediterranean diet over a 3-month period.

Lifestyle intervention group

Counseling and structured recommendations to increase regular physical activity over a 3-month period.

Lifestyle intervention group

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically confirmed hormone receptor-positive breast cancer
  • Breast cancer survivors receiving adjuvant endocrine therapy (tamoxifen or aromatase inhibitors) for ≥3 months
  • No recurrence or second primary malignancy
  • Ability to perform moderate-intensity physical activity
  • Consecutively recruited during routine surveillance visits

You may not qualify if:

  • Incomplete or discontinued hormone therapy
  • Concurrent ovarian suppression
  • Use of lipid-lowering medications
  • Severe uncontrolled comorbidities (e.g., diabetes, cardiac, or hepatic disease)
  • Cognitive or physical impairments preventing informed consent or participation
  • Restrictive dietary regimens

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Akid Othmane Hospital

Oran, Aïn-El-Turck, 31300, Algeria

Location

Related Publications (1)

  • Mohamedi ISM, Ghomari-Boukhatem H, Moussaoui I, Raiah M, Bouchenak M. Lifestyle factors and cardiometabolic risk in breast cancer patients under different hormones therapy. Med J Nutrition Metab. 2025; 18(3):194-203. doi:10.1177/1973798X251353349.

    BACKGROUND

MeSH Terms

Conditions

Cardiovascular DiseasesMotor Activity

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 17, 2026

First Posted

March 2, 2026

Study Start

May 2, 2022

Primary Completion

February 26, 2025

Study Completion

June 24, 2025

Last Updated

March 2, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. Only aggregated results, such as means and standard deviations of measured outcomes, will be published to evaluate the impact of the Mediterranean diet and physical activity promotion. All data will remain confidential and no personal identifiers will be made publicly available

Locations